effects [qlco]
Simvastatin [orch, phsu]
Carnitine [aapp, phsu]
Simvastatin [orch, phsu]
Lipoprotein (a) [aapp, bacs]
Apoprotein(a) [aapp, bacs]
Diabetes Mellitus, Type 2 [dsyn]
Present [qnco]
Study [mnob]
effects [qlco]
Simvastatin [orch, phsu]
L-Carnitine [aapp, phsu]
Simvastatin [orch, phsu]
Lipid [lipd]
Profile [lbpr]
Lipoprotein (a) [aapp, bacs]
Lp(a) [aapp, bacs]
Apoprotein(a) [aapp, bacs]
Apo-A [aapp, bacs]
Levels [qlco]
diabetic [fndg]
Patients [podg]
Patients [podg]
Methods [inpr]
DOUBLE BLIND [resa]
Randomized Clinical Trial [inpr, resa]
Patients [podg]
Assigned [ftcn]
treatment [ftcn]
Group [idcn]
months [tmco]
Group A [clas]
Received [qlco]
Simvastatin [orch, phsu]
Group [idcn]
Received [qlco]
L-Carnitine [aapp, phsu]
Simvastatin [orch, phsu]
Following [tmco]
variables [qlco]
Assessed [acty]
baseline [bodm]
Washout [tmco]
AT-1 [gngm]
months [tmco]
treatment [ftcn]
Body Mass Index [diap]
Fasting [fndg]
Plasma glucose [lbpr]
Glycated haemoglobin [aapp, bacs]
Total Cholesterol [lbpr]
Low density lipoprotein [aapp, bacs, lipd]
Cholesterol [bacs, strd]
High Density Lipoprotein Cholesterol [bacs, lipd]
Triglycerides [bacs, lipd]
Apolipoprotein [aapp, bacs]
Apo-B [aapp, bacs]
Lipoprotein (a) [aapp, bacs]
Apoprotein(a) [aapp, bacs]
End [spco]
treatment [ftcn]
Carnitine [aapp, phsu]
Simvastatin [orch, phsu]
Combined [qlco]
Group [idcn]
Compared [acty]
Simvastatin [orch, phsu]
Alone [qnco]
Group [idcn]
Observed [ftcn]
Decrease [qlco]
glycemia [carb]
P NOS [aapp, imft]
P NOS [aapp, imft]
Apo-B [aapp, bacs]
P NOS [aapp, imft]
Lp(a) [aapp, bacs]
P NOS [aapp, imft]
Apo-A [aapp, bacs]
P NOS [aapp, imft]
High density lipoprotein [aapp, bacs, lipd]
Increased [qnco]
P NOS [aapp, imft]
Conclusions [idcn]
Carnitine [aapp, phsu]
Simvastatin [orch, phsu]
reduction [npop]
Lp(a) [aapp, bacs]
Apo-A [aapp, bacs]
Represent [acty]
Therapeutic [topp]
Option [ftcn]
Reducing [qlco]
Plasma [bdsu]
Lp(a) [aapp, bacs]
Cholesterol, LDL [bacs, strd]
ApoB-100 [aapp, bacs]
